Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
mesna
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Generic mfg.
Drug class:
Antioxidant
Related drugs:
‹
ascorbic acid/menadione (0)
BMX-001 (0)
L-glutamine (0)
ascorbic acid/menadione (0)
BMX-001 (0)
L-glutamine (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
ifosfamide + epirubicin + mesna
Sensitive: A2 - Guideline
ifosfamide + epirubicin + mesna
Sensitive
:
A2
ifosfamide + epirubicin + mesna
Sensitive: A2 - Guideline
ifosfamide + epirubicin + mesna
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
doxorubicin hydrochloride + ifosfamide + mesna
Sensitive: A2 - Guideline
doxorubicin hydrochloride + ifosfamide + mesna
Sensitive
:
A2
doxorubicin hydrochloride + ifosfamide + mesna
Sensitive: A2 - Guideline
doxorubicin hydrochloride + ifosfamide + mesna
Sensitive
:
A2
Chr t(22)
Germ Cell Tumors
Chr t(22)
Germ Cell Tumors
cisplatin + ifosfamide + etoposide oral + mesna
Sensitive: C4 – Case Studies
cisplatin + ifosfamide + etoposide oral + mesna
Sensitive
:
C4
cisplatin + ifosfamide + etoposide oral + mesna
Sensitive: C4 – Case Studies
cisplatin + ifosfamide + etoposide oral + mesna
Sensitive
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login